User profiles for Dean Follmann
Dean FollmannAssistant Director for Biostatistics, NIAID Verified email at nih.gov Cited by 41302 |
Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans
…, K Mather, AD Baron, DA Follmann… - The Journal of …, 2000 - academic.oup.com
Insulin resistance plays an important role in the pathophysiology of diabetes and is associated
with obesity and other cardiovascular risk factors. The “gold standard” glucose clamp and …
with obesity and other cardiovascular risk factors. The “gold standard” glucose clamp and …
[HTML][HTML] Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase
…, L Corey, P Gilbert, H Janes, D Follmann… - … England Journal of …, 2021 - Mass Medical Soc
Background At interim analysis in a phase 3, observer-blinded, placebo-controlled clinical
trial, the mRNA-1273 vaccine showed 94.1% efficacy in preventing coronavirus disease 2019 …
trial, the mRNA-1273 vaccine showed 94.1% efficacy in preventing coronavirus disease 2019 …
Variance imputation for overviews of clinical trials with continuous response
D Follmann, P Elliott, IL Suh, J Cutler - Journal of clinical epidemiology, 1992 - Elsevier
Overviews of clinical trials are an efficient and important means of summarizing information
about a particular scientific area. When the outcome is a continuous variable, both treatment …
about a particular scientific area. When the outcome is a continuous variable, both treatment …
Randomized trials of sodium reduction: an overview
JA Cutler, D Follmann, PS Allender - The American journal of clinical …, 1997 - Elsevier
We updated a previously published overview of randomized clinical trials testing the effects
of reducing sodium intake. We excluded trials that had confounded designs, enrolled …
of reducing sodium intake. We excluded trials that had confounded designs, enrolled …
[HTML][HTML] A randomized trial of convalescent plasma in Covid-19 severe pneumonia
…, HG Michelangelo, D Follmann… - … England Journal of …, 2021 - Mass Medical Soc
Background Convalescent plasma is frequently administered to patients with Covid-19 and
has been reported, largely on the basis of observational data, to improve clinical outcomes. …
has been reported, largely on the basis of observational data, to improve clinical outcomes. …
[HTML][HTML] Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine
…, L Corey, P Gilbert, H Janes, D Follmann… - New England journal …, 2021 - Mass Medical Soc
Background Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to
protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid …
protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid …
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
In the coronavirus efficacy (COVE) phase 3 clinical trial, vaccine recipients were assessed
for neutralizing and binding antibodies as correlates of risk for COVID-19 disease and as …
for neutralizing and binding antibodies as correlates of risk for COVID-19 disease and as …
Effects of oral potassium on blood pressure: meta-analysis of randomized controlled clinical trials
… Appel, and Klag), and Division of Epidemiology and Clinical Applications, National Heart,
Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (Drs Cutler and Follmann)…
Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (Drs Cutler and Follmann)…
[HTML][HTML] A Covid-19 milestone attained—a correlate of protection for vaccines
…, Y Fong, SA Plotkin, D Follmann - … England Journal of …, 2022 - Mass Medical Soc
A Covid-19 Milestone Attained The rapid identification of a correlate of protection for Covid-
19 vaccines—on the basis of several harmonized randomized phase 3 trials using common …
19 vaccines—on the basis of several harmonized randomized phase 3 trials using common …
[HTML][HTML] Linezolid for treatment of chronic extensively drug-resistant tuberculosis
Background Linezolid has antimycobacterial activity in vitro and is increasingly used for
patients with highly drug-resistant tuberculosis. Methods We enrolled 41 patients who had …
patients with highly drug-resistant tuberculosis. Methods We enrolled 41 patients who had …